Search results
20 sty 2024 · Cervical cancer increasing in women in their 30s and 40s, new report finds. However, among women in their early 20s who have benefitted from the HPV vaccine, cervical cancer incidence...
2 mar 2021 · The results support the use of the HPV vaccine in HIV-infected patients and highlight the need of further RCTs assessing the effectiveness of the HPV vaccine on infections and neoplasms.
12 gru 2023 · A strategy of primary HPV DNA testing with a second triage test at a 5-yearly interval for women living with HIV was more effective at reducing cervical cancer cases and deaths than screening with visual inspection with acetic acid (VIA) every 3 years.
11 kwi 2022 · SAGE’s review concluded that a single-dose Human Papillomavirus (HPV) vaccine delivers solid protection against HPV, the virus that causes cervical cancer, that is comparable to 2-dose schedules. This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls.
20 lut 2023 · One-dose human papillomavirus (HPV) vaccination schedules are now recommended by the WHO. We explore HPV vaccination challenges and research needs for women living with HIV.
3 lip 2024 · vaccinate 90% of girls with preventive HPV vaccines; screen 70% of women with a high-performance test like HPV DNA screening; and. treat 90% of women who have precancerous cells in the cervix or cervical cancer. A therapeutic vaccine for HPV could supplement these existing approaches.
Among people living with HIV (PLHIV), who were seronegative for the vaccine type HPV infection prior to vaccination, seroconversion rates were high 28 weeks after receiving the first vaccine dose: more than 94% of PLHIV seroconverted for HPV-16/18 across three vaccines.
